Failure-To-Warn Claims Need Fail-Proof Evidence In NJ
The claims arose from breast cancer injuries allegedly sustained from certain hormone replacement therapy (HRT) pharmaceuticals. The plaintiffs contended that the manufacturers failed to provide adequate warnings of the risks allegedly associated between breast cancer and the HRT medications.
At issue was whether plaintiffs were able to circumvent New...
To view the full article, register now.